Shares in Pfizer (NYSE:PFE) fell slightly today even though the pharmaceutical giant beat expectations on Wall Street with its third quarter results.
The New York-based company posted profits of $2.84 billion, or 47¢ per share, on sales of $13.17 billion, for sales growth of 1% compared with last year’s third quarter results.
Get the full story at our sister site, Drug Delivery Business News.
The post Pfizer posts Street-beating Q3, raises full-year earnings forecast appeared first on MassDevice.